Oncode Institute is pleased to announce that 19 excellent scientists and their research groups join Oncode Institute per 2019. Oncode grows to 62 research groups, spread over 12 academic institutions throughout The Netherlands. With this expansion, Oncode welcomes a total of 4 new institutes: Amsterdam UMC - location VUMC, Leiden University, UMC Groningen and Sanquin.
The 19 new Oncode Investigators have been selected during two open recruitment calls. Both calls were very competitive, with over 160 applications in total. In the last call, 4 junior researchers and 7 senior researchers were appointed. Earlier in December, 7 Junior Investigators were announced to be part of the Oncode team. The 8th Junior Investigator of that call was appointed in early January. With these 19 new researchers on board, Oncode is at full capacity with over 800 fundamental cancer researchers in total.
The new researchers were selected on the basis of a careful and public selection procedure. The selection committee consisted of 8 Oncode researchers, complemented by 5 national and international experts and with input from the Oncode International Advisory Board. Prof. dr. Robert Benezra (Memorial Sloan Kettering Cancer Center, USA) who was involved in the selection process as an external expert, said: "We were impressed by the high quality of all candidates. With the final selection of researchers, Oncode strengthens its position as a leading fundamental oncology research institute in The Netherlands."
Prof. Geert Kops, Scientific Director of Oncode Institute, says: "We are proud that the team is now complete. With the team at full capacity, we can bring fundamental knowledge about molecular cancer biology a step further. We have added specific expertise in the field of tumor immunology and medicinal chemistry. Moreover, we now have four clinician-scientists on board, with which we will strengthen the link to the clinic."
Read more information on the selected Oncode Institute candidates here.
Source: Oncode Institute